Tuesday, October 27, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

[Efficacy and safety of domestic semaglutide injection in patients with type 2 diabetes mellitus inadequately controlled with metformin: a multicenter, randomized, controlled phase 3 equivalence clinical trial]

Zhonghua yi xue za zhi · 2026 Oct 26 · Wang WM, Tong GY, Zhao ZG et

MH
By Maren Holt · Senior Reporter, GLP-1
Oct 25 20:00 ETSource: Zhonghua yi xue za zhi

From the source

[Efficacy and safety of domestic semaglutide injection in patients with type 2 diabetes mellitus inadequately controlled with metformin: a multicenter, randomized, controlled phase 3 equivalence clinical trial]

Zhonghua yi xue za zhi · 2026 Oct 26 · Wang WM, Tong GY, Zhao ZG et al.

Read at pubmed.ncbi.nlm.nih.gov
PeptiPrescribed peptides from $99/moSee all →